Search Results - "Ambrozaitis, A"

Refine Results
  1. 1
  2. 2

    Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study by YANG, S.-H, LEE, C.-G, KHARCHENKO, N, YUN, Y.-D, KIM, C.-M, KIM, C.-Y, LEE, S.-H, KIM, B.-M, KIM, W.-B, SUNG, Y.-C, PARK, S.-H, IM, S.-J, KIM, Y.-M, SON, J.-M, WANG, J.-S, YOON, S.-K, SONG, M.-K, AMBROZAITIS, A

    Published in Gene therapy (01-07-2006)
    “…Despite recent advances in the chemotherapy of chronic hepatitis B (CHB), an effective viral suppression after cessation of therapy has not yet been achieved…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks by Schilling, M., Povinelli, L., Krause, P., Gravenstein, M., Ambrozaitis, A., Jones, H.H., Drinka, P., Shult, P., Powers, D., Gravenstein, S.

    Published in Vaccine (01-11-1998)
    “…Despite vaccination, influenza remains a common cause of morbidity in nursing homes. Chemoprophylaxis of residents with currently available antivirals is not…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    The macroepidemiology of influenza vaccination in 56 countries, 1997–2003

    Published in Vaccine (25-10-2005)
    “…The WHO Global Agenda on Influenza calls for measuring the progress of national influenza vaccination programs. In response, the Macroepidemiology of Influenza…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Hepatitis C Virus RNA Levels During Initial Induction or Standard Interferon Therapy: Influence of Continued Treatment on Sustained Response by Balciuniene, Ligita, Carlsson, Tony, Ambrozaitis, Arvydas, Reichard, Olle, Weiland, Ola

    “…Hepatitis C virus (HCV) RNA kinetics were studied at baseline weeks 4, 8 and 12 during interferon-α (IFN) monotherapy in 65 patients (mean age 39 y, range…”
    Get full text
    Journal Article
  20. 20

    Possibilities of eradicating the persistent HBsAg carrier state by Farber, N A, Ambrozaĭtis, A K, Kelli, E I, Vygodskiĭ, V S, Savitskiĭ, G I

    Published in Terapevtic̆eskii arhiv (1984)
    “…Five HBsAg carriers were examined by clinical, biochemical, radionuclide, immunologic and histomorphologic methods. Different variants of structural and…”
    Get more information
    Journal Article